Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial.

Cancer prevention research (Philadelphia, Pa.) - 1 Jan 2010

Thompson Patricia A, Hsu Chiu-Hsieh, Green Sylvan, Stopeck Alison T, Johnson Karen, Alberts David S, Chow H-H Sherry

Abstract excerpt

Regular use of nonsteroidal anti-inflammatory drugs (NSAID) has been associated with reduced risk of breast cancer. Sulindac, a nonselective NSAID with both cyclooxygenase-2-dependent and -independent activities, is a candidate for breast chemoprevention. We conducted a phase Ib trial in 30 women...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to C-Reactive Protein

Share to Carcinoma, Ductal, Breast

Share to Chromatography, High Pressure Liquid

Share to Dinoprostone

Share to Tissue Distribution

Source

Open in PubMed Open full text

Identifiers

PMID: 20051377
DOI: 10.1158/1940-6207.CAPR-09-0120
PMCID: PMC3993089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20051377-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial.PMID 20051377Read ↗

Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.Semantic proximity Read ↗

Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.Semantic proximity Read ↗

Selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancer.Semantic proximity Read ↗

Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women.Semantic proximity Read ↗

Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.Semantic proximity Read ↗

Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.Semantic proximity Read ↗

The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.Semantic proximity Read ↗

Oviduct fluid metabolic regulation of embryonic genome methylationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.